Goodwill of LIGAND PHARMACEUTICALS INC from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
LIGAND PHARMACEUTICALS INC quarterly Goodwill in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • LIGAND PHARMACEUTICALS INC Goodwill for the quarter ending 30 Sep 2025 was $101,541,000, a 3.5% decline year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

LIGAND PHARMACEUTICALS INC Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $101,541,000 -$3,709,000 -3.5% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $101,541,000 -$3,709,000 -3.5% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $101,541,000 -$3,709,000 -3.5% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $105,250,000 +$1,880,000 +1.8% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 $105,250,000 +$1,480,000 +1.4% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $105,250,000 -$423,000 -0.4% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $105,250,000 -$423,000 -0.4% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $103,370,000 +$103,370,000 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $103,770,000 -$77,436,000 -43% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $105,673,000 -$75,533,000 -42% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $105,673,000 -$75,533,000 -42% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $0 -$105,673,000 -100% 31 Dec 2022 10-K 28 Feb 2025 2024 FY
Q3 2022 $181,206,000 -$8,977,000 -4.7% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $181,206,000 -$9,311,000 -4.9% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $181,206,000 -$9,309,000 -4.9% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $105,673,000 -$83,989,000 -44% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $190,183,000 +$88,047,000 +86% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $190,517,000 +$87,148,000 +84% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $190,515,000 +$96,174,000 +102% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $189,662,000 +$94,433,000 +99% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $102,136,000 +$8,623,000 +9.2% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $103,369,000 +$15,369,000 +17% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $94,341,000 +$7,532,000 +8.7% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $95,229,000 +$8,583,000 +9.9% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $93,513,000 +$7,552,000 +8.8% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $88,000,000 +$2,039,000 +2.4% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $86,809,000 +$848,000 +0.99% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $86,646,000 +$687,000 +0.8% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q3 2018 $85,961,000 +$13,754,000 +19% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 $85,961,000 +$13,754,000 +19% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 $85,961,000 +$13,754,000 +19% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 $85,959,000 +$13,752,000 +19% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 $72,207,000 -$152,000 -0.21% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 $72,207,000 -$153,000 -0.21% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $72,207,000 -$790,000 -1.1% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 $72,207,000 +$59,969,000 +490% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 $72,359,000 +$60,121,000 +491% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 $72,360,000 +$60,122,000 +491% 30 Jun 2016 10-Q 14 Nov 2016 2016 Q2
Q1 2016 $72,997,000 +$60,759,000 +496% 31 Mar 2016 10-Q 14 Nov 2016 2016 Q1
Q4 2015 $12,238,000 $0 0% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q3 2015 $12,238,000 $0 0% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 $12,238,000 $0 0% 30 Jun 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 $12,238,000 $0 0% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 $12,238,000 $0 0% 31 Dec 2014 10-K 14 Nov 2016 2015 FY
Q3 2014 $12,238,000 $0 0% 30 Sep 2014 10-Q 31 Oct 2014 2014 Q3
Q2 2014 $12,238,000 $0 0% 30 Jun 2014 10-Q 05 Aug 2014 2014 Q2
Q1 2014 $12,238,000 $0 0% 31 Mar 2014 10-Q 07 May 2014 2014 Q1
Q4 2013 $12,238,000 $0 0% 31 Dec 2013 10-K 23 Feb 2015 2014 FY
Q3 2013 $12,238,000 $0 0% 30 Sep 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 $12,238,000 $0 0% 30 Jun 2013 10-Q 01 Aug 2013 2013 Q2
Q1 2013 $12,238,000 $0 0% 31 Mar 2013 10-Q 08 May 2013 2013 Q1
Q4 2012 $12,238,000 $0 0% 31 Dec 2012 10-K/A 12 Dec 2014 2013 FY
Q3 2012 $12,238,000 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 $12,238,000 30 Jun 2012 10-Q/A 14 Nov 2012 2012 Q2
Q1 2012 $12,238,000 31 Mar 2012 10-Q/A 14 Nov 2012 2012 Q1
Q4 2011 $12,238,000 +$11,538,000 +1648% 31 Dec 2011 10-K 14 Mar 2013 2012 FY
Q4 2010 $700,000 31 Dec 2010 10-K/A 14 Nov 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.